GlaxoSmithKline Pharmaceuticals (GSK) recently cut a deal with the Brazilian government, which allows it to supply a 10-valent vaccine against childhood pneumonia and other life-threatening infections for a decade at a fixed price in a reflection of the growing importance of vaccines and emerging markets to Big Pharma.
Links:
[1] http://admin.indiaenvironmentportal.org.in/news/big-pharma-gets-shot-arm
[2] http://admin.indiaenvironmentportal.org.in/category/author/gauri-kamath
[3] http://admin.indiaenvironmentportal.org.in/category/newspaper/business-world-kolkata
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/malaria
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drug-industry
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/immunisation
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/vaccination
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/hepatitis
[9] http://admin.indiaenvironmentportal.org.in/category/thesaurus/pneumonia
[10] http://admin.indiaenvironmentportal.org.in/category/thesaurus/who
[11] http://admin.indiaenvironmentportal.org.in/category/thesaurus/brazil